ALZN·02262M605·US·equity·Healthcare - Biotechnology-Activist
ALZN (ALZAMEND NEURO INC) is held by 5 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($48,420), MORGAN STANLEY ($19,080), CITIGROUP INC ($5,545). Net institutional sentiment: Mixed.
See how ALZN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer